Q4 2020 Holdings
Filed 2021-02-12 | 23 holdings | $2.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.7M | 490,877 | 83.2% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $86.9K | 2,532,150 | 4.1% |
| Oncorus Inc | COM | 68236R103 | $54.3K | 1,679,906 | 2.6% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $53.5K | 2,354,799 | 2.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $32.4K | 1,515,148 | 1.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $30.6K | 433,852 | 1.5% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $24.9K | 1,361,064 | 1.2% |
| Inozyme Pharma Inc | COM | 45790W108 | $20.5K | 995,396 | 1.0% |
| Akouos Inc | COM | 00973J101 | $17.3K | 870,897 | 0.8% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $12.7K | 2,931,185 | 0.6% |
| Precision Biosciences Inc | COM | 74019P108 | $7.1K | 852,358 | 0.3% |
| American Well Corp | CL A | 03044L105 | $6.3K | 248,352 | 0.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.9K | 827,260 | 0.1% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $1.1K | 62,000 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $987 | 22,800 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $705 | 135,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $642 | 59,209 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $617 | 5,500 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $415 | 3,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $346 | 8,000 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $54 | 10,000 | 0.0% |
| Precision Biosciences IncCall | COM | 74019P108 | $8 | 10,000 | 0.0% |
| Global Blood Therapeutics inCall | COM | 37890U108 | $8 | 20,000 | 0.0% |